Stocksigma LogoStocksigma Logo

Gaudium IVF Monitoring Agency Report Confirms Nil Deviation In IPO Proceeds Utilization

Infomerics Valuation and Rating released the Monitoring Agency Report for Gaudium IVF and Women Health for the quarter ended 30th Sep'26, confirming nil

Gaudium IVF Monitoring Agency Report Confirms Nil Deviation In IPO Proceeds Utilization

Gaudium IVF and Women Health Ltd 路 Others (Uncategorized) 路 13 Nov 2026, 5:08 am

Gaudium IVF Monitoring Agency Report Confirms Nil Deviation In IPO Proceeds Utilization Infomerics Valuation and Rating released the Monitoring Agency Report for Gaudium IVF and Women Health for the quarter ended 30th Sep'26, confirming nil material deviation from stated IPO objects. Out of total gross fresh issue proceeds of Rs 90.00 crore, cumulative utilization reached Rs 50.65 crore (Rs 16.62 crore utilized during the quarter), leaving Rs 39.35 crore unutilized, primarily held in HDFC Bank fixed deposits. The Board approved reallocating an unutilized borrowing repayment balance of Rs 1.93 crore toward General Corporate Purposes.

Original exchange filing (PDF)

More announcements from Gaudium IVF and Women Health Ltd

All Gaudium IVF and Women Health Ltd announcements